Tecogen Announces 2022 Results
Revenue of $25.0 million for FY 2022 up 2.5% compared to FY 2021
WALTHAM, MA, March 16, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Tecogen Inc. (OTCQX:TGEN), a leading manufacturer of clean energy products, reported a net loss of $1.4 million for the quarter ended December 31, 2022 and $2.4 million for the full year compared to net income of $0.1 million and $3.7 million, respectively, in 2021. The decrease in net income was due to lower gross profit and increased operating expenses in 2022, and the impact of the PPP loan forgiveness and Employee Retention Credit in 2021. Our gross margin decreased to 44.3% for the year ended December 31, 2022 compared to 47.5% for the same period in 2021. The year-end cash balance was $1.9 million and no debt.
Key Takeaways
Earnings Per Share
- Net income (loss) per share, basic and diluted, was $(0.10) per share for FY 2022 and $(0.06) per share for Q4 2022 compared to income of $0.15 and $0.00 per share for the same periods in 2021.
Income from Operations
- Operating loss was $1.4 million for the quarter compared to an operating profit of $0.1 million during the same period in 2021. The increase in our operating loss is due primarily to decreased revenue and margins for our Products Segment and increased operating expenses.
- For the year ended December 31, 2022, our loss from operations was $2.3 million compared to a loss of $1.2 million for the same period in 2021, an increase of $1.1 million. The increase in our loss from operations is due to the lower product margins in 2022 compared to 2021 due to higher material costs and, increased operating expenses.
Revenues
- Revenues for the quarter ended December 31, 2022 were $4.5 million compared to $7.2 million for the same period in 2021, a 36.9% decrease.
- Product revenue was $1.0 million in Q4 2022 compared to $3.7 million in the same period in 2021, a decrease of 72.9% primarily due to a decrease in both cogeneration and chiller sales.
- Services revenue was $3.0 million in Q4 2022 compared to $3.1 million in the same period in 2021, a decline of 2.3% due to reduced lower margin installation activity. Service contract revenue (O&M revenue) remained flat at $3.0 million.
- Energy Production revenue increased by $117.5 thousand, or 29.4%, to $517 thousand in Q4 2022 compared to $400 thousand in the same period in 2021.
- For the year ended December 31, 2022, revenues were $25.0 million compared to $24.4 million in FY 2021, an increase of $0.6 million or 2.5% year over year.
- Product revenue was $11.2 million in the 2022 compared to $10.1 million in FY 2021, an increase of 10.1%.
- Services revenue was $12.1 million for FY 2022 compared to $12.5 million in FY 2021, a decline of 3.7% due to reduced lower margin installation activity. Service contract revenue (O&M revenue) increased 4.1% to $12.1 million for FY 2022 compared to $11.6 million in FY 2021.
- Energy production revenue for FY 2022 was $1.8 million, compared to $1.7 million in FY 2021, an increase of 2.7%.
Gross Profit
- Gross profit for the fourth quarter of 2022 was $2.4 million compared to $3.5 million in the fourth quarter of 2021. Gross margin improved to 52.5% in the fourth quarter of 2022 compared to 48.1% for the same period in 2021. The decrease in product sales in the quarter resulted in a larger proportion of revenues from higher margin O&M service activities.
- Gross profit for FY 2022 was $11.1 million compared to $11.6 million for FY 2021, a decrease of 4.5%. For FY 2022 gross margin decreased to 44.3% compared to 47.5% for the same period in 2021 due to higher cost of materials.
Operating Expenses
- Operating expenses increased by 13.7% to $3.8 million for the fourth quarter of 2022 compared to $3.3 million in the same period of 2021. Operating expenses were higher in Q4 2022 primarily due to an overall increased in administrative costs, the impairment of long-lived assets, an increase in reserves for bad debt, a litigation provision, and increased R&D expenses associated with the development of the air-cooled chiller.
- For FY 2022 operating expenses increased $0.6 million, or 4.8%, to $13.4 million compared to $12.8 million for FY 2021. Operating expenses were higher in 2022 primarily due to an overall increase in administrative costs, a litigation provision, and increased R&D expenses associated with the development of the air-cooled chiller.
Adjusted EBITDA loss was $1,146 thousand for the fourth quarter of 2022 compared to income of $284 thousand for the fourth quarter. Operating expenses were higher in 2022 primarily due to an overall increase in administrative costs, the impairment of long-lived assets, an increase in reserves for bad debt, a litigation provision and increased R&D expenses associated with the development of the air-cooled chiller. For the year ended December 31, 2022 adjusted EBITDA loss was $1.7 million compared to EBITDA income of $0.7 million for FY 2021. The FY 2021 adjusted EBITDA benefited from the recognition of the $1.2 million in Employee Retention Credit. (Adjusted EBITDA is defined as net income or loss attributable to Tecogen, adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on equity securities, goodwill impairment charges and other non-cash non-recurring charges or gains including abandonment of intangible assets and the extinguishment of debt. See the table following the Condensed Consolidated Statements of Operations for a reconciliation from net income (loss) to Adjusted EBITDA, as well as important disclosures about the company’s use of Adjusted EBITDA).
“In the last month as CEO of Tecogen we have been implementing some significant strategic initiatives that we expect to bear fruit over the coming year,” commented Abinand Rangesh, Tecogen’s Chief Executive Officer. “We recently launched the hybrid air-cooled chiller at AHR 2023, which is the largest HVAC trade show in North America. It was well received with significant interest from a variety of parties. Additional color and a discussion of our strategic direction for 2023 and beyond will be discussed in our earnings call.”
Conference Call Scheduled for March 16, 2023 at 11:00 am ET
Tecogen will host a conference call on March 16, 2023 to discuss the fourth quarter results beginning at 11:00 am eastern time. To listen to the call please dial (877) 407-7186 within the U.S. and Canada, or (201) 689-8052 from other international locations. Participants should ask to be joined to the Tecogen FY 2022 earnings call. Please begin dialing 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the “News and Events” section under “About Us.” The earnings conference call will be webcast live. To view the associated slides, register for, and listen to the webcast, go to https://ir.tecogen.com/ir-calendar. Following the call, the recording will be archived for 14 days.
The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback, dial (877) 660-6853 within the U.S. and Canada, or (201) 612-7415 from other international locations and use Conference Call ID#: 13672659.
About Tecogen
Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint.
In business for over 35 years, Tecogen has shipped more than 3,150 units, supported by an established network of engineering, sales, and service personnel across the United States. Aggregate run hours on Tecogen’s InVerde e+ cogeneration systems exceeds 5 million hours. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.
Tecogen, InVerde e+, Ilios, Tecochill, Tecopower, Tecofrost, Tecopack and Ultera are registered or pending trademarks of Tecogen Inc.
Forward Looking Statements
This press release and any accompanying documents, contain “forward-looking statements” which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “project,” “target,” “potential,” “will,” “should,” “could,” “likely,” or “may” and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.
In addition to those factors described in our Annual Report on Form 10-K under “Risk Factors”, among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.
In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation. We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.
Tecogen Media & Investor Relations Contact Information:
Abinand Rangesh
P: 781-466-6487
E: Abinand.Rangesh@tecogen.com
Tecogen Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
As of December 31, 2022 and 2021 (unaudited)
| ASSETS | 2022 | 2021 | |
| Current assets: | |||
| Cash and cash equivalents | $ 1,913,969 | $ 3,614,463 | |
| Accounts receivable, net | 6,714,122 | 8,482,286 | |
| Employee retention credit receivable | 713,269 | 1,276,021 | |
| Unbilled revenue | 1,805,330 | 3,258,189 | |
| Inventory, net | 10,482,729 | 7,764,989 | |
| Prepaid and other current assets | 401,189 | 578,801 | |
| Total current assets | 22,030,608 | 24,974,749 | |
| Property, plant and equipment, net | 1,407,720 | 1,782,944 | |
| Right of use assets | 1,245,549 | 1,869,210 | |
| Intangible assets, net | 997,594 | 1,181,023 | |
| Goodwill | 2,406,156 | 2,406,156 | |
| Other assets | 165,230 | 148,140 | |
| TOTAL ASSETS | $28,252,857 | $32,362,222 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| Current liabilities: | |||
| Accounts payable | $ 3,261,952 | $ 3,508,354 | |
| Accrued expenses | 2,384,447 | 2,343,728 | |
| Deferred revenue | 1,115,627 | 1,957,752 | |
| Lease obligations | 687,589 | 641,002 | |
| Unfavorable contract liabilities | 236,705 | 330,032 | |
| Total current liabilities | 7,686,320 | 8,780,868 | |
| Long-term liabilities: | |||
| Deferred revenue, net of current portion | 371,823 | 208,456 | |
| Lease obligations, net of current portion | 623,452 | 1,315,275 | |
| Unfavorable contract liability, net of current portion | 583,512 | 929,474 | |
| Total liabilities | 9,265,107 | 11,234,073 | |
| Stockholders’ equity: | |||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 24,850,261 and 24,850,261 issued and outstanding at December 31, 2022 and 2021, respectively | 24,850 | 24,850 | |
| Additional paid-in capital | 57,351,008 | 57,016,859 | |
| Accumulated deficit | (38,281,548) | (35,833,621) | |
| Total Tecogen Inc. stockholders’ equity | 19,094,310 | 21,208,088 | |
| Noncontrolling interest | (106,560) | (79,939) | |
| Total stockholders’ equity | 18,987,750 | 21,128,149 | |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $28,252,857 | $32,362,222 |
TECOGEN INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three Months Ended December 31, 2022 and 2021
(unaudited)
| 2022 | 2021 | ||
| Revenues | |||
| Products | $ 999,771 | $ 3,693,349 | |
| Services | 3,014,586 | 3,086,891 | |
| Energy production | 517,230 | 399,702 | |
| Total revenues | 4,531,587 | 7,179,942 | |
| Cost of sales | |||
| Products | 678,855 | 1,999,637 | |
| Services | 1,202,800 | 1,450,945 | |
| Energy production | 270,693 | 277,488 | |
| Total cost of sales | 2,152,348 | 3,728,070 | |
| Gross profit | 2,379,239 | 3,451,872 | |
| Operating expenses | |||
| General and administrative | 3,267,067 | 2,437,727 | |
| Selling | 238,863 | 723,971 | |
| Research and Development | 195,747 | 161,015 | |
| Gain on sales of assets | — | (400) | |
| Long-lived asset impairment | 76,049 | — | |
| Total operating expenses | 3,777,726 | 3,322,313 | |
| Income (loss) from operations | (1,398,487) | 129,559 | |
| Other income (expense) | |||
| Interest and other income (expense) | (12,157) | (6,533) | |
| Interest expense | (415) | (655) | |
| Unrealized loss on investment securities | (18,749) | (56,246) | |
| Total other expense, net | (31,321) | (63,434) | |
| Income (loss) before income taxes | (1,429,808) | 66,125 | |
| Income tax provision | — | 500 | |
| Consolidated net income (loss) | (1,429,808) | 65,625 | |
| (Income) loss attributable to the noncontrolling interest | 5,402 | (2,659) | |
| Net income (loss) attributable to Tecogen Inc | $ (1,424,406) | $ 62,966 | |
| Net income (loss) per share – basic | $ (0.06) | $ — | |
| Weighted average shares outstanding – basic | 24,850,261 | 24,850,261 | |
| Net income (loss) per share – diluted | $ (0.06) | $ — | |
| Weighted average shares outstanding – diluted | 24,850,261 | 25,063,864 |
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three Months Ended December 31, 2022 and 2021
(unaudited)
| Non-GAAP financial disclosure (1) | 2022 | 2021 | |
| Net income (loss) attributable to Tecogen Inc | $ (1,424,406) | $ 62,966 | |
| Interest expense, net | 415 | 655 | |
| Provision for income taxes | — | 500 | |
| Depreciation and amortization, net | 103,381 | 112,218 | |
| EBITDA | (1,320,610) | 176,339 | |
| Stock-based compensation | 79,431 | 51,775 | |
| Unrealized loss on securities | 18,749 | 56,246 | |
| Long-lived asset impairment | 76,049 | — | |
| Adjusted EBITDA | $ (1,146,381) | $ 284,360 |
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Years Ended December 31, 2022 and 2021
(unaudited)
| 2022 | 2021 | ||
| Revenues | |||
| Products | $ 11,156,099 | $ 10,133,329 | |
| Services | 12,060,661 | 12,525,594 | |
| Energy production | 1,785,854 | 1,739,150 | |
| Total revenues | 25,002,614 | 24,398,073 | |
| Cost of sales | |||
| Products | 7,413,320 | 5,601,046 | |
| Services | 5,525,493 | 6,134,953 | |
| Energy production | 996,990 | 1,074,421 | |
| Total cost of sales | 13,935,803 | 12,810,420 | |
| Gross profit | 11,066,811 | 11,587,653 | |
| Operating expenses | |||
| General and administrative | 10,909,251 | 9,795,823 | |
| Selling | 1,811,085 | 2,471,929 | |
| Research and development | 732,873 | 542,079 | |
| Gain on sale of assets | (41,931) | (10,486) | |
| Long-lived asset impairment | 4,674 | 7,400 | |
| Total operating expenses | 13,415,952 | 12,806,745 | |
| Loss from operations | (2,349,141) | (1,219,092) | |
| Other income (expense) | |||
| Interest and other income | (34,713) | (23,746) | |
| Interest expense | (16,255) | (14,238) | |
| Gain on extinguishment of debt | — | 3,773,014 | |
| Employee Retention Credit | — | 1,276,021 | |
| Gain on the sale of investments | — | 6,046 | |
| Unrealized gain (loss) on investment securities | 18,749 | (37,497) | |
| Total other income (expense), net | (32,219) | 4,979,600 | |
| Income (loss) before income taxes | (2,381,360) | 3,760,508 | |
| State income tax provision | 16,352 | 19,491 | |
| Consolidated net income (loss) | (2,397,712) | 3,741,017 | |
| Income attributable to the noncontrolling interest | (50,215) | (45,017) | |
| Net income (loss) attributable to Tecogen Inc. | $ (2,447,927) | $ 3,696,000 | |
| Net income (loss) per share – basic | $ (0.10) | $ 0.15 | |
| Weighted average shares outstanding – basic | 24,850,261 | 24,850,261 | |
| Net income (loss) per share – diluted | $ (0.10) | $ 0.15 | |
| Weighted average shares outstanding -diluted | 24,850,261 | 25,115,518 | |
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Years Ended December 31, 2022 and 2021
(unaudited)
| Non-GAAP financial disclosure (1) | 2022 | 2021 | |
| Net income (loss) attributable to Tecogen Inc | $ (2,447,927) | $ 3,696,000 | |
| Provision for income taxes | 16,352 | 19,491 | |
| Interest expense, net | 16,255 | 14,238 | |
| Depreciation and amortization, net | 428,348 | 469,854 | |
| EBITDA | (1,986,972) | 4,199,583 | |
| Stock-based compensation | 334,149 | 202,431 | |
| Gain on extinguishment of debt | — | (3,773,014) | |
| Unrealized loss on investment securities | (18,749) | 31,451 | |
| Asset impairment | 4,674 | 7,400 | |
| Adjusted EBITDA (2) | $ (1,666,898) | $ 667,851 |
(1) Non-GAAP Financial Measures
In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, this news release contains information about Adjusted EBITDA (net income (loss) attributable to Tecogen Inc adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges including abandonment of certain intangible assets and extinguishment of debt), which is a non-GAAP measure. The Company believes Adjusted EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results. Adjusted EBITDA is not calculated through the application of GAAP. Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.
(2) Employee Retention Credit
The adjusted EBITDA in 2021 benefits from $1.2 million of Employee Retention Credit.
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 2022 and 2021
(unaudited)
| 2022 | 2021 | |||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
| Consolidated net income (loss) | $ (2,397,712) | $ 3,741,017 | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||
| Depreciation, accretion and amortization, net | 428,348 | 469,854 | ||
| Gain on the extinguishment of debt | — | (3,773,014) | ||
| Employee retention credit | — | (1,276,021) | ||
| Long-lived asset impairment | 4,674 | 7,400 | ||
| Gain on sale of assets | (41,931) | (10,486) | ||
| Provision for doubtful accounts receivable | (70,987) | 131,206 | ||
| Gain on the sale of investments | — | (6,046) | ||
| Provision for litigation | 150,000 | — | ||
| Provision for inventory reserve | 107,000 | |||
| Unrealized (gain) loss on investment securities | (18,749) | 37,497 | ||
| Stock-based compensation | 334,149 | 202,431 | ||
| Changes in operating assets and liabilities: | ||||
| (Increase) decrease in: | ||||
| Accounts receivable | 2,401,904 | 57,618 | ||
| Inventory, net | (2,824,740) | (596,393) | ||
| Unbilled revenue | 1,452,860 | 1,009,060 | ||
| Prepaid expenses and other current assets | 177,612 | 18,343 | ||
| Other non-current assets | 625,320 | (231,478) | ||
| Increase (decrease) in: | ||||
| Accounts payable | (246,401) | (674,750) | ||
| Accrued expenses | (109,282) | 374,802 | ||
| Deferred revenue | (678,758) | 756,722 | ||
| Other current liabilities | (645,236) | 227,271 | ||
| Net cash (used in) provided by operating activities | (1,351,929) | 465,033 | ||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||
| Purchases of property and equipment | (314,879) | (91,451) | ||
| Proceeds on sale of property and equipment | 72,655 | 10,486 | ||
| Purchases of intangible assets | (29,505) | (63,097) | ||
| Proceeds from sale of investments | — | 11,637 | ||
| Distributions to noncontrolling interest | (76,836) | (82,633) | ||
| Net used in investing activities | (348,565) | (215,058) | ||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
| Proceeds from note payable | — | 1,874,269 | ||
| Net cash provided by financing activities | — | 1,874,269 | ||
| Change in cash and cash equivalents | (1,700,494) | 2,124,244 | ||
| Cash and cash equivalents, beginning of the year | 3,614,463 | 1,490,219 | ||
| Cash and cash equivalents, end of the year | $ 1,913,969 | $ 3,614,463 |
